XRTX · XORTX Therapeutics Inc.
$2.06
+0.01 (+0.49%)
At close · Jul 29
Market Cap
$26.76M
Shares
12.99M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.06
Open$2.06
Day$2.01–2.09
52W$1.73–7.05
Avg vol 30d15K
Short int24K · 0.2% float · 1.8d
Short vol9%
DataSep 2021–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 20.7 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−20%
below
Price vs 50-day avg
−5%
below
RSI (14)
48
neutral
MACD trend
Positive
52-week position
6%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−5%
trailing
6-month return
−16%
trailing
YTD return
−27%
this year
Relative strength
−22%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Flat
1 of 3 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.18% of float · ▼ -5.7% MoM · 1.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
3 holders — near 2-yr low, contrarian setup
Squeeze score
36
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
97%
annualized · 1-yr
Max drawdown
−69%
past year
ATR
5.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−20%
Bearish
Price vs 50-day avg
−5%
Neutral
RSI (14)
48
Neutral
MACD trend
Positive
Bullish
52-week position
6%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Flat
1 of 3 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.18% of float · ▼ -5.7% MoM · 1.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
3 holders — near 2-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $2
Now $2 · 6%
52-wk high $7
vs 200-day avg -20%
vs 50-day avg -5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
XRTX
this stock
XORTX Therapeutics Inc.
|
$26.76M | -26.7% | — | — | 0.2% |
|
ONC
BeOne Medicines Ltd.
|
$472.90B | +7.7% | +22179.2% | 962.4 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$122.67B | +6.6% | +46.2% | 28.7 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$72.91B | -9.8% | +20.8% | 17.0 | 3.3% |
|
ARGX
Argenx SE
|
$55.21B | +4.9% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Holders
3
- % held
- 0.0%
- Reported
- 1 of 3
- Top holder
- Kingsview Wealth Manageme…
Held
Float
Short & Settlement
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XRTX | +2.5% | -5.1% | -15.9% | -5.1% | -26.7% |
| SPY | -2.4% | -2.3% | +6.3% | -2.3% | +7.0% |
| vs SPY | +4.9% | -2.8% | -22.2% | -2.8% | -33.7% |